Anthracycline Use Linked to More than Doubling in Heart Failure Risk, Study Finds
An analysis of data from the Rochester Epidemiology Project suggests those with breast cancer or lymphoma who received treatment with anthracycline therapy experienced a more than doubling in risk of heart failure compared to controls without cancer.